The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Animal Model Market Projected To Become By 2030 Based On Its 2026 Valuation?
The animal model market has experienced robust expansion in recent years. It is anticipated to grow from $2.07 billion in 2025 to $2.24 billion in 2026, at a compound annual growth rate (CAGR) of 8.5%. The market’s past growth can be attributed to several factors, including the increasing prevalence of chronic diseases, a rising demand for preclinical research, growth in pharmaceutical R&D initiatives, advancements in laboratory equipment technology, and the expansion of academic research institutions.
The animal model market is projected to experience robust expansion over the coming years, with its size anticipated to reach $2.97 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.3%. This growth during the forecast period can be attributed to several factors, including the integration of AI and machine learning in preclinical research, the rise of precision medicine initiatives, the expansion of contract research organizations (CROs) and outsourcing, the proliferation of genetically modified animal models, and an increased focus on translational research. Major trends expected in this period encompass the development of advanced animal models, the adoption of genetically engineered models, the implementation of high-throughput screening in preclinical studies, the integration of imaging and diagnostic tools, and the continued expansion of contract research organizations.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp
What Primary Drivers Are Shaping The Development Of The Animal Model Market?
Increased investment in pharmaceutical research and development (R&D) is anticipated to drive the expansion of the animal model market. This R&D encompasses the discovery, creation, and evaluation of novel therapies, demanding comprehensive preclinical investigations to assess their safety, effectiveness, and biological workings prior to human trials. The surge in R&D expenditure stems from an increasing demand for innovative treatments, a rising incidence of complex diseases, and ongoing scientific progress. Animal models are crucial in this sequence, offering dependable preclinical platforms that simulate human physiology, thereby facilitating the predictive evaluation of drug performance. As an illustration, a November 2023 report from the European Federation of Pharmaceutical Industries and Associations, a trade association based in Belgium, indicated that pharmaceutical industry research and development expenditure escalated to 50,000 million in 2023, an increase from 47,010 million in 2022. Consequently, the escalating pharmaceutical R&D expenditure is fueling the expansion of the animal model market.
What Segment Groups Are Identified Within The Animal Model Market?
The animal model market covered in this report is segmented –
1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies
3) By Application: Drug Discovery And Development, Basic Research, Other Applications
4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations
Subsegments:
1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice
2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats
3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs
4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds
5) By Hamsters: Syrian Hamsters, Chinese Hamsters
6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)
What Trends Are Advancing Progress In The Animal Model Market?
Leading companies operating in the animal model market are concentrating on developing innovative products, such as triple-immunodeficient animal models. This focus aims to enhance the accuracy and reliability of preclinical studies, support advanced biomedical research, and facilitate the development of novel therapies for complex human diseases. Triple-immunodeficient animal models are specially engineered animals, typically mice, that lack three key immune system components. These models are invaluable in biomedical research, particularly for studying human diseases and developing new treatments. For instance, in January 2024, Charles River Laboratories International, Inc., a US-based pharmaceutical company, launched NCG mouse strains, a triple-immunodeficient mouse model for oncology research. NCG mice are characterized by triple immunodeficiency, lacking functional/mature T, B, and NK cells, and also exhibit reduced macrophage and dendritic cell function. These animal models are capable of hosting xenograft cells, tissues, and human immune system components. This mouse model is ideal for research in oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant studies. Furthermore, NCG mice can be used to create humanized mice by engrafting PBMCs or CD34+ stem cells, thereby closely mimicking the human immune system.
Which Companies Hold Significant Positions In The Animal Model Market?
Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd, Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd, Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.
Read the full animal model market report here:
https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report
How Does The Animal Model Market Perform Across Major Global Regions?
North America was the largest region in the animal model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Animal Model Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15510&type=smp
Browse Through More Reports Similar to the Global Animal Model Market 2026, By The Business Research Company
Animal Model Market Report 2026
https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report
Rat Model Market Report 2026
https://www.thebusinessresearchcompany.com/report/rat-model-global-market-report
Anatomical Models Market Report 2026
https://www.thebusinessresearchcompany.com/report/anatomical-models-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model